John A. Barranger

Overview

Best Publications

• Fabry disease, an under-recognized multisystemic disorder: expert recommendations for diagnosis, management, and enzyme replacement therapy.

  Robert J. Desnick;Roscoe Brady;John Barranger;Allan J. Collins

  959
  Citations

• A mutation in the human glucocerebrosidase gene in neuronopathic Gaucher's disease.

  Shoji Tsuji;Prabhakara V. Choudary;Brian M. Martin;Barbara K. Stubblefield

  440
  Citations

• Clinical trial to assess the safety, feasibility, and efficacy of transferring a potentially anti-arthritic cytokine gene to human joints with rheumatoid arthritis

  Principal Investigator: Christopher H. Evans;Henry J. Mankin;Co-Principal Investigator: Paul D. Robbins;Co-Investigator: Steve C. Ghivizzani

  368
  Citations

• Uptake and distribution of placental glucocerebrosidase in rat hepatic cells and effects of sequential deglycosylation

  F.Scott Furbish;Clifford J. Steer;Nancy L. Krett;John A. Barranger

  302
  Citations

• Efficient transfer and sustained high expression of the human glucocerebrosidase gene in mice and their functional macrophages following transplantation of bone marrow transduced by a retroviral vector.

  Toya Ohashi;Sallie Boggs;Paul Robbins;Alfred Bahnson

  265
  Citations

• Genetic heterogeneity in type 1 Gaucher disease: multiple genotypes in Ashkenazic and non-Ashkenazic individuals.

  Shoji Tsuji;Brian M. Martin;John A. Barranger;Barbara K. Stubblefield

  247
  Citations

• Centrifugal enhancement of retroviral mediated gene transfer.

  A B Bahnson;J T Dunigan;B E Baysal;T Mohney

  240
  Citations

• Relationship between production and release of lymphocyte-activating factor (interleukin 1) by murine macrophages. 1. Effects of various agents

  Igal Gery;Igal Gery;Philip Davies;Philip Davies;Julia Derr;Julia Derr;Nancy Krett;Nancy Krett

  226
  Citations

• Transplantation of human hepatocytes.

  S.C. Strom;R.A. Fisher;W.S. Rubinstein;J.A. Barranger

  224
  Citations

• Skeletal complications of Gaucher disease.

  Daniel W. Stowens;Steven L. Teitelbaum;Arnold J. Kahn;John A. Barranger

  220
  Citations

• Human gene marker/therapy clinical protocols.

  S. A. Rosenberg;R. M. Blaese;M. K. Brenner;A. B. Deisseroth

  214
  Citations

• Biosynthesis of the lysosomal enzyme glucocerebrosidase.

  A H Erickson;E I Ginns;J A Barranger

  203
  Citations

• Structure of the N-asparagine-linked oligosaccharide units of human placental beta-glucocerebrosidase.

  S Takasaki;G J Murray;F S Furbish;R O Brady

  188
  Citations

• Cytogenetic analysis of 39 pediatric central nervous system tumors.

  Pamela S. Karnes;Tuan N. Tran;Mei Ying Cui;Corey Raffel

  182
  Citations

• Improvement of bone disease by imiglucerase (Cerezyme) therapy in patients with skeletal manifestations of type 1 Gaucher disease: results of a 48-month longitudinal cohort study.

  KB Sims;GM Pastores;NJ Weinreb;J Barranger

  159
  Citations

• Mutations of glucocerebrosidase: discrimination of neurologic and non-neurologic phenotypes of Gaucher disease.

  E I Ginns;R O Brady;S Pirruccello;C Moore

  156
  Citations

• Nucleotide sequence of cDNA containing the complete coding sequence for human lysosomal glucocerebrosidase.

  S. Tsuji;Prabhakara V Choudary;B. M. Martin;S. Winfield

  154
  Citations

• Identification of the neurotrophic factor sequence of prosaposin.

  John S. O'Brien;Geoffrey S. Carson;Hee-Chan Seo;Masao Hiraiwa

  149
  Citations

• Gene mapping and leader polypeptide sequence of human glucocerebrosidase: implications for Gaucher disease

  Edward I. Ginns;Prabhakara V. Choudary;Shoji Tsuji;Brian Martin

  144
  Citations

• Evaluation of Gaucher disease using magnetic resonance imaging.

  D I Rosenthal;J A Scott;J Barranger;H J Mankin

  143
  Citations